Field Trials of Live and Inactivated Camelpox Vaccines in Kazakhstan
Mambetaliyev M. Kilibayev S. Kenzhebaeva M. Sarsenkulova N. Tabys S. Valiyeva A. Muzarap D. Tuyskanova M. Myrzakhmetova B. Rametov N. Sarbassova A. Nurgaziev R. Kerimbayev A. Babiuk S. Zhugunissov K.
June 2024Multidisciplinary Digital Publishing Institute (MDPI)
Vaccines
2024#12Issue 6
An outbreak of camelpox occurred in the Mangistau region of Kazakhstan in 2019. To control the outbreak of camelpox and to prevent its further spread to other regions, camels were vaccinated using live and inactivated camelpox vaccines produced in Kazakhstan. To evaluate the efficacy of these camelpox vaccines in the field, vaccine trials used 172 camels on camel farms in the Beineu district. Of these, 132 camels were vaccinated using a live attenuated camelpox vaccine and 40 camels were vaccinated using an inactivated vaccine to observe immunogenicity and safety. The live vaccine was inoculated into camels by scarification at a dose of 5 × 104 EID50, and the inactivated vaccine was injected intramuscularly at 5 mL twice, with an interval of 35 days. During the safety evaluation, camels administered either vaccine displayed no clinical signs of illness or any adverse effects. Post-vaccination seroconversion demonstrated that the live attenuated vaccine started to elicit antibody responses in some animals as early as day seven, while, by day 28, 99% of vaccinated camels responded. For camels immunized with the inactivated vaccine, seroconversion began on day 21 at low titers ranging from 1:2 to 1:4. Ninety days post vaccination, 77% of the camels demonstrated an immune response that was up to a titer of 1:16. The antibody response waned six months post vaccination in camels vaccinated with two types of vaccine. Nonetheless, both vaccines were 100% effective at preventing clinical disease in vaccinated camels during the camelpox outbreak. All unvaccinated camels became ill, with manifestations of clinical signs characteristic of camelpox. Following these successful field trials in Kazakhstan, a vaccination program for camels, to control camelpox using the domestically produced live attenuated camelpox vaccine, has started.
camelpox , field trial , immunogenicity , inactivated vaccine , live vaccine , safety , scarification
Text of the article Перейти на текст статьи
Research Institute for Biological Safety Problems, Gvardeiysky, 080409, Kazakhstan
Institute of Ionosphere, Almaty, 050020, Kazakhstan
Department of Geospatial Engineering, Satpayev Kazakh National Research Technical University, Almaty, 050013, Kazakhstan
Department of Social Sciences, Satpayev Kazakh National Research Technical University, Almaty, 050013, Kazakhstan
Department of Infectious Animal Diseases, Skryabin Kyrgyz State Agrarian University, Bishkek, 720000, Kyrgyzstan
National Centre for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg, R3E 3M4, MB, Canada
Department of Immunology, University of Manitoba, Winnipeg, R3T 2N2, MB, Canada
Research Institute for Biological Safety Problems
Institute of Ionosphere
Department of Geospatial Engineering
Department of Social Sciences
Department of Infectious Animal Diseases
National Centre for Foreign Animal Disease
Department of Immunology
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026